<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37662922</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Neutrophils: a subgroup of neglected immune cells in ALS.</ArticleTitle><Pagination><StartPage>1246768</StartPage><MedlinePgn>1246768</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1246768</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1246768</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a chronic, progressive neurodegenerative disease characterized by the loss of motor neurons. Dysregulated peripheral immunity has been identified as a hallmark of ALS. Neutrophils, as the front-line responders of innate immunity, contribute to host defense through pathogen clearance. However, they can concurrently play a detrimental role in chronic inflammation.&#xa0;With the unveiling of novel functions of neutrophils in neurodegenerative diseases, it becomes essential to review our current understanding of neutrophils and to recognize the gap in our knowledge about their role in ALS. Thus, a detailed comprehension of the biological processes underlying neutrophil-induced pathogenesis in ALS may assist in identifying potential cell-based therapeutic strategies to delay disease progression.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Cao and Fan.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Disorders, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Dongsheng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Disorders, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">MPO</Keyword><Keyword MajorTopicYN="N">degranulation</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">neutrophils</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>4</Hour><Minute>51</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37662922</ArticleId><ArticleId IdType="pmc">PMC10468589</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1246768</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, et al. . Amyotrophic lateral sclerosis. Lancet (2022) 400(10360):1363&#x2013;80. doi:&#xa0;10.1016/S0140-6736(22)01272-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01272-7</ArticleId><ArticleId IdType="pmc">PMC10089700</ArticleId><ArticleId IdType="pubmed">36116464</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Boum&#xe9;diene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. . Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol (2017) 46(1):57&#x2013;74. doi:&#xa0;10.1093/ije/dyw061</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw061</ArticleId><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mora G, Moglia C, Manera U, Canosa A, Cammarosano S, et al. . Secular trends of amyotrophic lateral sclerosis: the piemonte and valle d'Aosta register. JAMA Neurol (2017) 74(9):1097&#x2013;104. doi:&#xa0;10.1001/jamaneurol.2017.1387</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.1387</ArticleId><ArticleId IdType="pmc">PMC5710181</ArticleId><ArticleId IdType="pubmed">28692730</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan M, Gomez N, Hsieh C, Bekier M, Li X, Miguez R, et al. . RNA methylation influences TDP43 binding and disease pathogenesis in models of amyotrophic lateral sclerosis and frontotemporal dementia. Mol Cell (2023) 83(2):219&#x2013;36.e7. doi:&#xa0;10.1016/j.molcel.2022.12.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.12.019</ArticleId><ArticleId IdType="pmc">PMC9899051</ArticleId><ArticleId IdType="pubmed">36634675</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk TR, Rousseaux M. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener (2020) 15(1):45. doi:&#xa0;10.1186/s13024-020-00397-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W, He J, Cai X, Yu Z, Zou Z, Fan D. Neuroimmune crosstalk between the peripheral and the central immune system in amyotrophic lateral sclerosis. Front Aging Neurosci (2022) 14:890958. doi:&#xa0;10.3389/fnagi.2022.890958</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.890958</ArticleId><ArticleId IdType="pmc">PMC9110796</ArticleId><ArticleId IdType="pubmed">35592701</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdani S, Seitz C, Cui C, Lovik A, Pan L, Piehl F, et al. . T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat Commun (2022) 13(1):6733. doi:&#xa0;10.1038/s41467-022-34526-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34526-9</ArticleId><ArticleId IdType="pmc">PMC9643478</ArticleId><ArticleId IdType="pubmed">36347843</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, Monteagudo A, Murdock BJ, Famie JP, Webber-Davis IF, Piecuch CE, et al. . Tofacitinib suppresses natural killer cells in vitro and in vivo: implications for amyotrophic lateral sclerosis. Front Immunol (2022) 13:773288. doi:&#xa0;10.3389/fimmu.2022.773288</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.773288</ArticleId><ArticleId IdType="pmc">PMC8859451</ArticleId><ArticleId IdType="pubmed">35197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui C, Ingre C, Yin L, Li X, Andersson J, Seitz C, et al. . Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis. Elife (2022) 11. doi:&#xa0;10.7554/eLife.74065</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.74065</ArticleId><ArticleId IdType="pmc">PMC8923665</ArticleId><ArticleId IdType="pubmed">35287794</ArticleId></ArticleIdList></Reference><Reference><Citation>Trolese MC, Scarpa C, Melfi V, Fabbrizio P, Sironi F, Rossi M, et al. . Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice. Mol Ther (2022) 30(8):2760&#x2013;84. doi:&#xa0;10.1016/j.ymthe.2022.04.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2022.04.018</ArticleId><ArticleId IdType="pmc">PMC9372324</ArticleId><ArticleId IdType="pubmed">35477657</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, King PH, Si Y, Kwon Y, Varela V, Ibarburu S, et al. . Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight (2018) 3(19). doi:&#xa0;10.1172/jci.insight.123249</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123249</ArticleId><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo S, Cocozza G, Bernardini G, Savage J, Raspa M, Aronica E, et al. . Blocking immune cell infiltration of the central nervous system to tame Neuroinflammation in Amyotrophic lateral sclerosis. Brain Behav Immun (2022) 105:1&#x2013;14. doi:&#xa0;10.1016/j.bbi.2022.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.06.004</ArticleId><ArticleId IdType="pubmed">35688338</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff JR, Berry JD, Macklin EA, Beers DR, Mendoza PA, Zhao W, et al. . Combined regulatory T-lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm (2022) 9(6). doi:&#xa0;10.1212/NXI.0000000000200019</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200019</ArticleId><ArticleId IdType="pmc">PMC9423710</ArticleId><ArticleId IdType="pubmed">36038262</ArticleId></ArticleIdList></Reference><Reference><Citation>Polg&#xe1;r TF, Meszl&#xe9;nyi V, N&#xf3;gr&#xe1;di B, K&#xf6;rm&#xf6;czy L, Spis&#xe1;k K, Tripolszki K, et al. . Passive transfer of blood sera from ALS patients with identified mutations results in elevated motoneuronal calcium level and loss of motor neurons in the spinal cord of mice. Int J Mol Sci (2021) 22(18). doi:&#xa0;10.3390/ijms22189994</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22189994</ArticleId><ArticleId IdType="pmc">PMC8470779</ArticleId><ArticleId IdType="pubmed">34576165</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi L, Chizari S, Ho J, Gromova A, Arnold FJ, Mosca L, et al. . Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4. Nature (2022) 606(7916):945&#x2013;52. doi:&#xa0;10.1038/s41586-022-04844-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04844-5</ArticleId><ArticleId IdType="pmc">PMC10089623</ArticleId><ArticleId IdType="pubmed">35732742</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Bender DE, Kashlan SR, Figueroa-Romero C, Backus C, Callaghan BC, et al. . Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm (2016) 3(4):e242. doi:&#xa0;10.1212/NXI.0000000000000242</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000242</ArticleId><ArticleId IdType="pmc">PMC4897983</ArticleId><ArticleId IdType="pubmed">27308304</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol (2017) 74(12):1446&#x2013;54. doi:&#xa0;10.1001/jamaneurol.2017.2255</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Yang W, Wei Q, Shang H. Causal association of leukocytes count and amyotrophic lateral sclerosis: a mendelian randomization study. Mol Neurobiol (2020) 57(11):4622&#x2013;7. doi:&#xa0;10.1007/s12035-020-02053-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02053-7</ArticleId><ArticleId IdType="pubmed">32770314</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Goutman SA, Boss J, Kim S, Feldman EL. Amyotrophic lateral sclerosis survival associates with neutrophils in a sex-specific manner. Neurol Neuroimmunol Neuroinflamm (2021) 8(2). doi:&#xa0;10.1212/NXI.0000000000000953</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000953</ArticleId><ArticleId IdType="pmc">PMC8057067</ArticleId><ArticleId IdType="pubmed">33531377</ArticleId></ArticleIdList></Reference><Reference><Citation>McGill RB, Steyn FJ, Ngo ST, Thorpe KA, Heggie S, Ruitenberg MJ, et al. . Monocytes and neutrophils are associated with clinical features in amyotrophic lateral sclerosis. Brain Commun (2020) 2(1):fcaa013. doi:&#xa0;10.1093/braincomms/fcaa013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa013</ArticleId><ArticleId IdType="pmc">PMC7530830</ArticleId><ArticleId IdType="pubmed">33033799</ArticleId></ArticleIdList></Reference><Reference><Citation>Keizman D, Rogowski O, Berliner S, Ish-Shalom M, Maimon N, Nefussy B, et al. . Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis. Acta Neurol Scand (2009) 119(6):383&#x2013;9. doi:&#xa0;10.1111/j.1600-0404.2008.01112.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2008.01112.x</ArticleId><ArticleId IdType="pubmed">18976328</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SJ, Hong YH, Kim SM, Shin JY, Suh YJ, Sung JJ. High neutrophil-to-lymphocyte ratio predicts short survival duration in amyotrophic lateral sclerosis. Sci Rep (2020) 10(1):428. doi:&#xa0;10.1038/s41598-019-57366-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-57366-y</ArticleId><ArticleId IdType="pmc">PMC6965090</ArticleId><ArticleId IdType="pubmed">31949271</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei QQ, Hou YB, Zhang LY, Ou RW, Cao B, Chen YP, et al. . Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis. Neural Regener Res (2022) 17(4):875&#x2013;80. doi:&#xa0;10.4103/1673-5374.322476</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.322476</ArticleId><ArticleId IdType="pmc">PMC8530123</ArticleId><ArticleId IdType="pubmed">34472488</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone MA, Mandrioli J, Russo S, Cucovici A, Gianferrari G, Lisnic V, et al. . Neutrophils-to-lymphocyte ratio is associated with progression and overall survival in amyotrophic lateral sclerosis. Biomedicines (2022) 10(2). doi:&#xa0;10.3390/biomedicines10020354</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10020354</ArticleId><ArticleId IdType="pmc">PMC8962424</ArticleId><ArticleId IdType="pubmed">35203564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinda D, Nakaji S, Umeda T, Shimoyama T, Kurakake S, Okamura N, et al. . A competitive marathon race decreases neutrophil functions in athletes. Luminescence (2003) 18(6):324&#x2013;9. doi:&#xa0;10.1002/bio.744</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bio.744</ArticleId><ArticleId IdType="pubmed">14694421</ArticleId></ArticleIdList></Reference><Reference><Citation>Meininger V, Drory VE, Leigh PN, Ludolph A, Robberecht W, Silani V. Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial. Amyotroph Lateral Scler (2009) 10(5-6):378&#x2013;83. doi:&#xa0;10.3109/17482960902803432</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902803432</ArticleId><ArticleId IdType="pubmed">19922128</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol (2011) 11(8):519&#x2013;31. doi:&#xa0;10.1038/nri3024</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3024</ArticleId><ArticleId IdType="pubmed">21785456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol (2013) 13(3):159&#x2013;75. doi:&#xa0;10.1038/nri3399</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3399</ArticleId><ArticleId IdType="pubmed">23435331</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin KR, Wong HL, Witko-Sarsat V, Wicks IP. G-CSF - A double edge sword in neutrophil mediated immunity. Semin Immunol (2021) 54:101516. doi:&#xa0;10.1016/j.smim.2021.101516</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2021.101516</ArticleId><ArticleId IdType="pubmed">34728120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hidalgo A, Chilvers ER, Summers C, Koenderman L. The neutrophil life cycle. Trends Immunol (2019) 40(7):584&#x2013;97. doi:&#xa0;10.1016/j.it.2019.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2019.04.013</ArticleId><ArticleId IdType="pubmed">31153737</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol (2010) 31(8):318&#x2013;24. doi:&#xa0;10.1016/j.it.2010.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2010.05.006</ArticleId><ArticleId IdType="pmc">PMC2930213</ArticleId><ArticleId IdType="pubmed">20620114</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash A, Medhi B, Chopra K. Granulocyte colony stimulating factor (GCSF) improves memory and neurobehavior in an amyloid-&#x3b2; induced experimental model of Alzheimer's disease. Pharmacol Biochem Behav (2013) 110:46&#x2013;57. doi:&#xa0;10.1016/j.pbb.2013.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbb.2013.05.015</ArticleId><ArticleId IdType="pubmed">23756182</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X, Ping S, Kyle M, Chin L, Zhao LR. Long-term beneficial effects of hematopoietic growth factors on brain repair in the chronic phase of severe traumatic brain injury. Exp Neurol (2020) 330:113335. doi:&#xa0;10.1016/j.expneurol.2020.113335</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113335</ArticleId><ArticleId IdType="pubmed">32360282</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich J, Baryawno N, Nayyar N, Valtis YK, Yang B, Ly I, et al. . Bone marrow drives central nervous system regeneration after radiation injury. J Clin Invest (2018) 128(1):281&#x2013;93. doi:&#xa0;10.1172/JCI90647</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90647</ArticleId><ArticleId IdType="pmc">PMC5749546</ArticleId><ArticleId IdType="pubmed">29202481</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitzer C, Kr&#xfc;ger C, Plaas C, Kirsch F, Dittgen T, M&#xfc;ller R, et al. . Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain (2008) 131(Pt 12):3335&#x2013;47. doi:&#xa0;10.1093/brain/awn243</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn243</ArticleId><ArticleId IdType="pmc">PMC2639207</ArticleId><ArticleId IdType="pubmed">18835867</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider A, Kr&#xfc;ger C, Steigleder T, Weber D, Pitzer C, Laage R, et al. . The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest (2005) 115(8):2083&#x2013;98. doi:&#xa0;10.1172/JCI23559</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI23559</ArticleId><ArticleId IdType="pmc">PMC1172228</ArticleId><ArticleId IdType="pubmed">16007267</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Pitzer C, Dittgen T, Klugmann M, Dupuis L, Schneider A. CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit. Mol Ther (2011) 19(2):284&#x2013;92. doi:&#xa0;10.1038/mt.2010.271</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2010.271</ArticleId><ArticleId IdType="pmc">PMC3034860</ArticleId><ArticleId IdType="pubmed">21139572</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheshachalam A, Srivastava N, Mitchell T, Lacy P, Eitzen G. Granule protein processing and regulated secretion in neutrophils. Front Immunol (2014) 5:448. doi:&#xa0;10.3389/fimmu.2014.00448</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00448</ArticleId><ArticleId IdType="pmc">PMC4168738</ArticleId><ArticleId IdType="pubmed">25285096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang X, Chen S, Zhu J, Ma J, Zhai Y. The emerging role of central and peripheral immune systems in neurodegenerative diseases. Front Aging Neurosci (2022) 14:872134. doi:&#xa0;10.3389/fnagi.2022.872134</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.872134</ArticleId><ArticleId IdType="pmc">PMC9082639</ArticleId><ArticleId IdType="pubmed">35547626</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Cao W, Yang Y, Liu A. Extensive infiltration of neutrophils in the acute phase of experimental autoimmune encephalomyelitis in C57BL/6 mice. Histochem Cell Biol (2010) 133(3):313&#x2013;22. doi:&#xa0;10.1007/s00418-009-0673-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-009-0673-2</ArticleId><ArticleId IdType="pubmed">20063008</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajramovic JJ, Brok HP, Ouwerling B, Jagessar SA, van Straalen L, Kondova I, et al. . Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve. Eur J Immunol (2008) 38(5):1452&#x2013;64. doi:&#xa0;10.1002/eji.200737164</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200737164</ArticleId><ArticleId IdType="pubmed">18412169</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth L, Rustenhoven J, Park TI, Schweder P, Jansson D, Heppner PA, et al. . Unique and shared inflammatory profiles of human brain endothelia and pericytes. J Neuroinflamm (2018) 15(1):138. doi:&#xa0;10.1186/s12974-018-1167-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1167-8</ArticleId><ArticleId IdType="pmc">PMC5948925</ArticleId><ArticleId IdType="pubmed">29751771</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansson D, Dieriks VB, Rustenhoven J, Smyth L, Scotter E, Aalderink M, et al. . Cardiac glycosides target barrier inflammation of the vasculature, meninges and choroid plexus. Commun Biol (2021) 4(1):260. doi:&#xa0;10.1038/s42003-021-01787-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01787-x</ArticleId><ArticleId IdType="pmc">PMC7910294</ArticleId><ArticleId IdType="pubmed">33637884</ArticleId></ArticleIdList></Reference><Reference><Citation>Arts JJ, Mahlandt EK, Gr&#xf6;nloh ML, Schimmel L, Noordstra I, Gordon E, et al. . Endothelial junctional membrane protrusions serve as hotspots for neutrophil transmigration. Elife (2021) 10. doi:&#xa0;10.7554/eLife.66074</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.66074</ArticleId><ArticleId IdType="pmc">PMC8437435</ArticleId><ArticleId IdType="pubmed">34431475</ArticleId></ArticleIdList></Reference><Reference><Citation>Scali C, Prosperi C, Bracco L, Piccini C, Baronti R, Ginestroni A, et al. . Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's disease. Neurobiol Aging (2002) 23(4):523&#x2013;30. doi:&#xa0;10.1016/s0197-4580(01)00346-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0197-4580(01)00346-3</ArticleId><ArticleId IdType="pubmed">12009501</ArticleId></ArticleIdList></Reference><Reference><Citation>Baik SH, Cha MY, Hyun YM, Cho H, Hamza B, Kim DK, et al. . Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model. Neurobiol Aging (2014) 35(6):1286&#x2013;92. doi:&#xa0;10.1016/j.neurobiolaging.2014.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.003</ArticleId><ArticleId IdType="pmc">PMC4248665</ArticleId><ArticleId IdType="pubmed">24485508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zenaro E, Pietronigro E, Della Bianca V, Piacentino G, Marongiu L, Budui S, et al. . Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med (2015) 21(8):880&#x2013;6. doi:&#xa0;10.1038/nm.3913</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3913</ArticleId><ArticleId IdType="pubmed">26214837</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, Guo K, Murdock BJ, Paez-Colasante X, Bassis CM, Mikhail KA, et al. . Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Dis Model Mech (2019) 13(2). doi:&#xa0;10.1242/dmm.041947</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.041947</ArticleId><ArticleId IdType="pmc">PMC6906635</ArticleId><ArticleId IdType="pubmed">31597644</ArticleId></ArticleIdList></Reference><Reference><Citation>Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol (2012) 30:459&#x2013;89. doi:&#xa0;10.1146/annurev-immunol-020711-074942</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-020711-074942</ArticleId><ArticleId IdType="pubmed">22224774</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Hossain M, Thanabalasuriar A, Gunzer M, Meininger C, Kubes P. Visualizing the function and fate of neutrophils in sterile injury and repair. Science (2017) 358(6359):111&#x2013;6. doi:&#xa0;10.1126/science.aam9690</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aam9690</ArticleId><ArticleId IdType="pubmed">28983053</ArticleId></ArticleIdList></Reference><Reference><Citation>Borregaard N, S&#xf8;rensen OE, Theilgaard-M&#xf6;nch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol (2007) 28(8):340&#x2013;5. doi:&#xa0;10.1016/j.it.2007.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2007.06.002</ArticleId><ArticleId IdType="pubmed">17627888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N, Aiyasiding X, Li WJ, Liao HH, Tang QZ. Neutrophil degranulation and myocardial infarction. Cell Commun Signal (2022) 20(1):50. doi:&#xa0;10.1186/s12964-022-00824-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-022-00824-4</ArticleId><ArticleId IdType="pmc">PMC8996539</ArticleId><ArticleId IdType="pubmed">35410418</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali I, Khan SN, Chatzicharalampous C, Bai D, Abu-Soud HM. Catalase prevents myeloperoxidase self-destruction in response to oxidative stress. J Inorg Biochem (2019) 197:110706. doi:&#xa0;10.1016/j.jinorgbio.2019.110706</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinorgbio.2019.110706</ArticleId><ArticleId IdType="pubmed">31103890</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizo-T&#xe9;llez SA, Sekheri M, Filep JG. Myeloperoxidase: regulation of neutrophil function and target for therapy. Antioxid (Basel) (2022) 11(11). doi:&#xa0;10.3390/antiox11112302</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11112302</ArticleId><ArticleId IdType="pmc">PMC9687284</ArticleId><ArticleId IdType="pubmed">36421487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray RS, Katyal A. Myeloperoxidase: Bridging the gap in neurodegeneration. Neurosci Biobehav Rev (2016) 68:611&#x2013;20. doi:&#xa0;10.1016/j.neubiorev.2016.06.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2016.06.031</ArticleId><ArticleId IdType="pubmed">27343997</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzikas S, Schlak D, Sopova K, Gatsiou A, Stakos D, Stamatelopoulos K, et al. . Increased myeloperoxidase plasma levels in patients with Alzheimer's disease. J Alzheimers Dis (2014) 39(3):557&#x2013;64. doi:&#xa0;10.3233/JAD-131469</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-131469</ArticleId><ArticleId IdType="pubmed">24217274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright JR, Deen Q, Stevenson A, Telford-Cooke LL, Parker C, Martin-Ruiz C, et al. . Plasma myeloperoxidase as a potential biomarker of patient response to anti-dementia treatment in alzheimer's disease. J Alzheimers Dis (2022) 89(4):1483&#x2013;92. doi:&#xa0;10.3233/JAD-220642</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220642</ArticleId><ArticleId IdType="pubmed">36057826</ArticleId></ArticleIdList></Reference><Reference><Citation>Teismann P. [Myeloperoxidase in the neurodegenerative process of Parkinson's disease]. Dtsch Med Wochenschr (2014) 139(3):99&#x2013;102. doi:&#xa0;10.1055/s-0033-1359907</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0033-1359907</ArticleId><ArticleId IdType="pubmed">24277448</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellhaar S, Sunnemark D, Eriksson H, Olson L, Galter D. Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease. Cell Tissue Res (2017) 369(3):445&#x2013;54. doi:&#xa0;10.1007/s00441-017-2626-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-017-2626-8</ArticleId><ArticleId IdType="pmc">PMC5579172</ArticleId><ArticleId IdType="pubmed">28466093</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth L, Murray HC, Hill M, van Leeuwen E, Highet B, Magon NJ, et al. . Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer's disease. Acta Neuropathol Commun (2022) 10(1):38. doi:&#xa0;10.1186/s40478-022-01347-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-022-01347-2</ArticleId><ArticleId IdType="pmc">PMC8944147</ArticleId><ArticleId IdType="pubmed">35331340</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkman R, Ben-Zur T, Kahana A, Garty BZ, Offen D. Myeloperoxidase deficiency inhibits cognitive decline in the 5XFAD mouse model of alzheimer's disease. Front Neurosci (2019) 13:990. doi:&#xa0;10.3389/fnins.2019.00990</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00990</ArticleId><ArticleId IdType="pmc">PMC6769081</ArticleId><ArticleId IdType="pubmed">31611761</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J, Pan J, Mo J, Peng Y. MPO/HOCl facilitates apoptosis and ferroptosis in the SOD1(G93A) motor neuron of amyotrophic lateral sclerosis. Oxid Med Cell Longev (2022) 2022:8217663. doi:&#xa0;10.1155/2022/8217663</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/8217663</ArticleId><ArticleId IdType="pmc">PMC8845144</ArticleId><ArticleId IdType="pubmed">35178161</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xdc;llen A, Singewald E, Konya V, Fauler G, Reicher H, Nusshold C, et al. . Myeloperoxidase-derived oxidants induce blood-brain barrier dysfunction in vitro and in vivo . PloS One (2013) 8(5):e64034. doi:&#xa0;10.1371/journal.pone.0064034</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064034</ArticleId><ArticleId IdType="pmc">PMC3653856</ArticleId><ArticleId IdType="pubmed">23691142</ArticleId></ArticleIdList></Reference><Reference><Citation>van Leeuwen E, Hampton MB, Smyth L. Hypothiocyanous acid disrupts the barrier function of brain endothelial cells. Antioxid (Basel) (2022) 11(4). doi:&#xa0;10.3390/antiox11040608</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11040608</ArticleId><ArticleId IdType="pmc">PMC9030776</ArticleId><ArticleId IdType="pubmed">35453292</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiuolo J, Gliozzi M, Musolino V, Scicchitano M, Carresi C, Scarano F, et al. . The "Frail" Brain blood barrier in neurodegenerative diseases: role of early disruption of endothelial cell-to-cell connections. Int J Mol Sci (2018) 19(9). doi:&#xa0;10.3390/ijms19092693</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19092693</ArticleId><ArticleId IdType="pmc">PMC6164949</ArticleId><ArticleId IdType="pubmed">30201915</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins CL. Hypochlorous acid-mediated modification of proteins and its consequences. Essays Biochem (2020) 64(1):75&#x2013;86. doi:&#xa0;10.1042/EBC20190045</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/EBC20190045</ArticleId><ArticleId IdType="pubmed">31867603</ArticleId></ArticleIdList></Reference><Reference><Citation>Vile GF, Rothwell LA, Kettle AJ. Hypochlorous acid activates the tumor suppressor protein p53 in cultured human skin fibroblasts. Arch Biochem Biophys (1998) 359(1):51&#x2013;6. doi:&#xa0;10.1006/abbi.1998.0881</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.1998.0881</ArticleId><ArticleId IdType="pubmed">9799559</ArticleId></ArticleIdList></Reference><Reference><Citation>Vissers MC, Winterbourn CC. Oxidation of intracellular glutathione after exposure of human red blood cells to hypochlorous acid. Biochem J (1995) 307(Pt 1):57&#x2013;62. doi:&#xa0;10.1042/bj3070057</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3070057</ArticleId><ArticleId IdType="pmc">PMC1136744</ArticleId><ArticleId IdType="pubmed">7717994</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xfc;tz WA. Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch Biochem Biophys (1996) 332(1):110&#x2013;20. doi:&#xa0;10.1006/abbi.1996.0322</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.1996.0322</ArticleId><ArticleId IdType="pubmed">8806715</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozonet SM, Magon NJ, Schwartfeger AJ, Konigstorfer A, Heath SG, Vissers M, et al. . Oxidation of caspase-8 by hypothiocyanous acid enables TNF-mediated necroptosis. J Biol Chem (2023) 299(6):104792. doi:&#xa0;10.1016/j.jbc.2023.104792</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2023.104792</ArticleId><ArticleId IdType="pmc">PMC10267563</ArticleId><ArticleId IdType="pubmed">37150321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y, et al. . RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science (2016) 353(6299):603&#x2013;8. doi:&#xa0;10.1126/science.aaf6803</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>Polverino E, Rosales-Mayor E, Dale GE, Dembowsky K, Torres A. The role of neutrophil elastase inhibitors in lung diseases. Chest (2017) 152(2):249&#x2013;62. doi:&#xa0;10.1016/j.chest.2017.03.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2017.03.056</ArticleId><ArticleId IdType="pubmed">28442313</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasus-Jacobi A, Washburn JL, Land CA, Pereira HA. Neutrophil granule proteins inhibit amyloid beta aggregation and neurotoxicity. Curr Alzheimer Res (2021) 18(5):414&#x2013;27. doi:&#xa0;10.2174/1567205018666210823095044</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205018666210823095044</ArticleId><ArticleId IdType="pmc">PMC9791948</ArticleId><ArticleId IdType="pubmed">34429047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BW, Jeong KH, Kim JH, Jin M, Kim JH, Lee MG, et al. . Pathogenic upregulation of glial lipocalin-2 in the parkinsonian dopaminergic system. J Neurosci (2016) 36(20):5608&#x2013;22. doi:&#xa0;10.1523/JNEUROSCI.4261-15.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4261-15.2016</ArticleId><ArticleId IdType="pmc">PMC6601774</ArticleId><ArticleId IdType="pubmed">27194339</ArticleId></ArticleIdList></Reference><Reference><Citation>Naud&#xe9; PJ, Nyakas C, Eiden LE, Ait-Ali D, van der Heide R, Engelborghs S, et al. . Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J (2012) 26(7):2811&#x2013;23. doi:&#xa0;10.1096/fj.11-202457</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.11-202457</ArticleId><ArticleId IdType="pmc">PMC3382095</ArticleId><ArticleId IdType="pubmed">22441986</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Nimer F, Elliott C, Bergman J, Khademi M, Dring AM, Aeinehband S, et al. . Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination. Neurol Neuroimmunol Neuroinflamm (2016) 3(1):e191. doi:&#xa0;10.1212/NXI.0000000000000191</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000191</ArticleId><ArticleId IdType="pmc">PMC4708925</ArticleId><ArticleId IdType="pubmed">26770997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST, Steyn FJ, Huang L, Mantovani S, Pfluger CM, Woodruff TM, et al. . Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. J Neurol Sci (2015) 357(1-2):22&#x2013;7. doi:&#xa0;10.1016/j.jns.2015.06.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.06.053</ArticleId><ArticleId IdType="pubmed">26198021</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrozziello T, Mills AN, Farhan S, Mueller KA, Granucci EJ, Glajch KE, et al. . Lipocalin-2 is increased in amyotrophic lateral sclerosis. Muscle Nerve (2020) 62(2):272&#x2013;83. doi:&#xa0;10.1002/mus.26911</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26911</ArticleId><ArticleId IdType="pubmed">32369618</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjeldsen L, Bainton DF, Sengel&#xf8;v H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood (1994) 83(3):799&#x2013;807. doi: 10.1182/blood.V83.3.799.799</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V83.3.799.799</ArticleId><ArticleId IdType="pubmed">8298140</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjeldsen L, Johnsen AH, Sengel&#xf8;v H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem (1993) 268(14):10425&#x2013;32. doi: 10.1016/S0021-9258(18)82217-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)82217-7</ArticleId><ArticleId IdType="pubmed">7683678</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha MK, Lee S, Park DH, Kook H, Park KG, Lee IK, et al. . Diverse functional roles of lipocalin-2 in the central nervous system. Neurosci Biobehav Rev (2015) 49:135&#x2013;56. doi:&#xa0;10.1016/j.neubiorev.2014.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2014.12.006</ArticleId><ArticleId IdType="pubmed">25511817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SS, Ren Y, Liu CC, Kurti A, Baker KE, Bu G, et al. . Lipocalin-2 protects the brain during inflammatory conditions. Mol Psychiatry (2018) 23(2):344&#x2013;50. doi:&#xa0;10.1038/mp.2016.243</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.243</ArticleId><ArticleId IdType="pmc">PMC5503822</ArticleId><ArticleId IdType="pubmed">28070126</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi F, Huang C, Tong J, Qiu G, Huang B, Wu Q, et al. . Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci U.S.A. (2013) 110(10):4069&#x2013;74. doi:&#xa0;10.1073/pnas.1218497110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1218497110</ArticleId><ArticleId IdType="pmc">PMC3593910</ArticleId><ArticleId IdType="pubmed">23431168</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Lee WH, Lee MS, Mori K, Suk K. Regulation by lipocalin-2 of neuronal cell death, migration, and morphology. J Neurosci Res (2012) 90(3):540&#x2013;50. doi:&#xa0;10.1002/jnr.22779</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22779</ArticleId><ArticleId IdType="pubmed">22038922</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, Jang E, Suk K. Lipocalin-2 acts as a neuroinflammatogen in lipopolysaccharide-injected mice. Exp Neurobiol (2014) 23(2):155&#x2013;62. doi:&#xa0;10.5607/en.2014.23.2.155</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2014.23.2.155</ArticleId><ArticleId IdType="pmc">PMC4065829</ArticleId><ArticleId IdType="pubmed">24963280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Jha MK, Suk K. Lipocalin-2 in the inflammatory activation of brain astrocytes. Crit Rev Immunol (2015) 35(1):77&#x2013;84. doi:&#xa0;10.1615/critrevimmunol.2015012127</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/critrevimmunol.2015012127</ArticleId><ArticleId IdType="pubmed">26111426</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang E, Lee S, Kim JH, Kim JH, Seo JW, Lee WH, et al. . Secreted protein lipocalin-2 promotes microglial M1 polarization. FASEB J (2013) 27(3):1176&#x2013;90. doi:&#xa0;10.1096/fj.12-222257</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.12-222257</ArticleId><ArticleId IdType="pubmed">23207546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Lee S, Park HC, Lee WH, Lee MS, Suk K. Modulation of glial and neuronal migration by lipocalin-2 in zebrafish. Immune Netw (2011) 11(6):342&#x2013;7. doi:&#xa0;10.4110/in.2011.11.6.342</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2011.11.6.342</ArticleId><ArticleId IdType="pmc">PMC3275702</ArticleId><ArticleId IdType="pubmed">22346773</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res (2006) 69(3):562&#x2013;73. doi:&#xa0;10.1016/j.cardiores.2005.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2005.12.002</ArticleId><ArticleId IdType="pubmed">16405877</ArticleId></ArticleIdList></Reference><Reference><Citation>Fertin M, Lemesle G, Turkieh A, Beseme O, Chwastyniak M, Amouyel P, et al. . Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction. PloS One (2013) 8(8):e71280. doi:&#xa0;10.1371/journal.pone.0071280</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0071280</ArticleId><ArticleId IdType="pmc">PMC3743841</ArticleId><ArticleId IdType="pubmed">23967183</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorsa T, Tervahartiala T, Leppilahti J, Hernandez M, Gamonal J, Tuomainen AM, et al. . Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res (2011) 63(2):108&#x2013;13. doi:&#xa0;10.1016/j.phrs.2010.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2010.10.005</ArticleId><ArticleId IdType="pubmed">20937384</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti S, Patel KD. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J Leukoc Biol (2005) 78(1):279&#x2013;88. doi:&#xa0;10.1189/jlb.1004612</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1004612</ArticleId><ArticleId IdType="pubmed">15831558</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Zhang L, Yao X, Hu J, Yu L, Jia H, et al. . Association studies of MMP-9 in Parkinson's disease and amyotrophic lateral sclerosis. PloS One (2013) 8(9):e73777. doi:&#xa0;10.1371/journal.pone.0073777</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073777</ArticleId><ArticleId IdType="pmc">PMC3767588</ArticleId><ArticleId IdType="pubmed">24040066</ArticleId></ArticleIdList></Reference><Reference><Citation>Demestre M, Parkin-Smith G, Petzold A, Pullen AH. The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis. J Neuroimmunol (2005) 159(1-2):146&#x2013;54. doi:&#xa0;10.1016/j.jneuroim.2004.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2004.09.015</ArticleId><ArticleId IdType="pubmed">15652414</ArticleId></ArticleIdList></Reference><Reference><Citation>I&#x142;zecka J, Stelmasiak Z, Dobosz B. Matrix metalloproteinase-9 (MMP-9) activity in cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurol Neurochir Pol (2001) 35(6):1035&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">11987700</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj-Dobosz I, Janik P, Soko&#x142;owska B, Kwiecinski H. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Neurol (2010) 17(2):226&#x2013;31. doi:&#xa0;10.1111/j.1468-1331.2009.02775.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02775.x</ArticleId><ArticleId IdType="pubmed">19796283</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L, Huber-Abel F, Teuchert M, Hendrich C, Dorst J, Schattauer D, et al. . Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). J Neurol Sci (2009) 285(1-2):62&#x2013;6. doi:&#xa0;10.1016/j.jns.2009.05.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2009.05.025</ArticleId><ArticleId IdType="pubmed">19523650</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewil M, Schurmans C, Starckx S, Opdenakker G, Van Den Bosch L, Robberecht W. Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis. Neuroreport (2005) 16(4):321&#x2013;4. doi:&#xa0;10.1097/00001756-200503150-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200503150-00003</ArticleId><ArticleId IdType="pubmed">15729130</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzl S, Narr S, Angele B, Krell HW, Gregorio J, Kiaei M, et al. . The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice. Exp Neurol (2006) 200(1):166&#x2013;71. doi:&#xa0;10.1016/j.expneurol.2006.01.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2006.01.026</ArticleId><ArticleId IdType="pubmed">16516196</ArticleId></ArticleIdList></Reference><Reference><Citation>Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, et al. . Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol (2005) 289(2):H558&#x2013;68. doi:&#xa0;10.1152/ajpheart.01275.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.01275.2004</ArticleId><ArticleId IdType="pubmed">15764676</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Khan T, Dominique MA, Restrepo CR, Cotton-Samuel D, Levitan M, et al. . Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP-43-triggered death in rNLS8 mice. Neurobiol Dis (2019) 124:133&#x2013;40. doi:&#xa0;10.1016/j.nbd.2018.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.11.013</ArticleId><ArticleId IdType="pmc">PMC7053168</ArticleId><ArticleId IdType="pubmed">30458231</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiaei M, Kipiani K, Calingasan NY, Wille E, Chen J, Heissig B, et al. . Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol (2007) 205(1):74&#x2013;81. doi:&#xa0;10.1016/j.expneurol.2007.01.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2007.01.036</ArticleId><ArticleId IdType="pubmed">17362932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A, Spiller KJ, Towne C, Kanning KC, Choe GT, Geber A, et al. . Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron (2014) 81(2):333&#x2013;48. doi:&#xa0;10.1016/j.neuron.2013.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.009</ArticleId><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. . Neutrophil extracellular traps kill bacteria. Science (2004) 303(5663):1532&#x2013;5. doi:&#xa0;10.1126/science.1092385</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1092385</ArticleId><ArticleId IdType="pubmed">15001782</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeli I, Dwivedi N, Khan S, Radic M. Regulation of extracellular chromatin release from neutrophils. J Innate Immun (2009) 1(3):194&#x2013;201. doi:&#xa0;10.1159/000206974</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000206974</ArticleId><ArticleId IdType="pmc">PMC6951038</ArticleId><ArticleId IdType="pubmed">20375577</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald B, Urrutia R, Yipp BG, Jenne CN, Kubes P. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe (2012) 12(3):324&#x2013;33. doi:&#xa0;10.1016/j.chom.2012.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.06.011</ArticleId><ArticleId IdType="pubmed">22980329</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L, et al. . A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med (2008) 14(12):1377&#x2013;83. doi:&#xa0;10.1038/nm.1878</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1878</ArticleId><ArticleId IdType="pmc">PMC2710311</ArticleId><ArticleId IdType="pubmed">19029985</ArticleId></ArticleIdList></Reference><Reference><Citation>DiStasi MR, Ley K. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol (2009) 30(11):547&#x2013;56. doi:&#xa0;10.1016/j.it.2009.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2009.07.012</ArticleId><ArticleId IdType="pmc">PMC2767453</ArticleId><ArticleId IdType="pubmed">19783480</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Ley K. Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol (2008) 172(1):1&#x2013;7. doi:&#xa0;10.2353/ajpath.2008.070502</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.070502</ArticleId><ArticleId IdType="pmc">PMC2189633</ArticleId><ArticleId IdType="pubmed">18079440</ArticleId></ArticleIdList></Reference><Reference><Citation>Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR. Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab (2015) 35(6):888&#x2013;901. doi:&#xa0;10.1038/jcbfm.2015.45</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2015.45</ArticleId><ArticleId IdType="pmc">PMC4640255</ArticleId><ArticleId IdType="pubmed">25806703</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeltz S, Mu&#xf1;oz LE, Fuchs TA, Herrmann M. Neutrophil extracellular traps open the pandora's box in severe malaria. Front Immunol (2017) 8:874. doi:&#xa0;10.3389/fimmu.2017.00874</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00874</ArticleId><ArticleId IdType="pmc">PMC5532516</ArticleId><ArticleId IdType="pubmed">28804484</ArticleId></ArticleIdList></Reference><Reference><Citation>Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, et al. . Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PloS One (2012) 7(2):e32366. doi:&#xa0;10.1371/journal.pone.0032366</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032366</ArticleId><ArticleId IdType="pmc">PMC3289648</ArticleId><ArticleId IdType="pubmed">22389696</ArticleId></ArticleIdList></Reference><Reference><Citation>Meegan JE, Yang X, Beard RS, Jr, Jannaway M, Chatterjee V, Taylor-Clark TE, et al. . Citrullinated histone 3 causes endothelial barrier dysfunction. Biochem Biophys Res Commun (2018) 503(3):1498&#x2013;502. doi:&#xa0;10.1016/j.bbrc.2018.07.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.07.069</ArticleId><ArticleId IdType="pmc">PMC6119499</ArticleId><ArticleId IdType="pubmed">30029877</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai W, Liu S, Hu M, Huang F, Zhu Q, Qiu W, et al. . Functional dynamics of neutrophils after ischemic stroke. Transl Stroke Res (2020) 11(1):108&#x2013;21. doi:&#xa0;10.1007/s12975-019-00694-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-019-00694-y</ArticleId><ArticleId IdType="pmc">PMC6993940</ArticleId><ArticleId IdType="pubmed">30847778</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietronigro EC, Della Bianca V, Zenaro E, Constantin G. NETosis in alzheimer's disease. Front Immunol (2017) 8:211. doi:&#xa0;10.3389/fimmu.2017.00211</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00211</ArticleId><ArticleId IdType="pmc">PMC5332471</ArticleId><ArticleId IdType="pubmed">28303140</ArticleId></ArticleIdList></Reference><Reference><Citation>Allam R, Kumar SV, Darisipudi MN, Anders HJ. Extracellular histones in tissue injury and inflammation. J Mol Med (Berl) (2014) 92(5):465&#x2013;72. doi:&#xa0;10.1007/s00109-014-1148-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-014-1148-z</ArticleId><ArticleId IdType="pubmed">24706102</ArticleId></ArticleIdList></Reference><Reference><Citation>McPherson CA, Merrick BA, Harry GJ. In vivo molecular markers for pro-inflammatory cytokine M1 stage and resident microglia in trimethyltin-induced hippocampal injury. Neurotox Res (2014) 25(1):45&#x2013;56. doi:&#xa0;10.1007/s12640-013-9422-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-013-9422-3</ArticleId><ArticleId IdType="pmc">PMC3880630</ArticleId><ArticleId IdType="pubmed">24002884</ArticleId></ArticleIdList></Reference><Reference><Citation>Moxon-Emre I, Schlichter LC. Neutrophil depletion reduces blood-brain barrier breakdown, axon injury, and inflammation after intracerebral hemorrhage. J Neuropathol Exp Neurol (2011) 70(3):218&#x2013;35. doi:&#xa0;10.1097/NEN.0b013e31820d94a5</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31820d94a5</ArticleId><ArticleId IdType="pubmed">21293296</ArticleId></ArticleIdList></Reference><Reference><Citation>Monif M, Burnstock G, Williams DA. Microglia: proliferation and activation driven by the P2X7 receptor. Int J Biochem Cell Biol (2010) 42(11):1753&#x2013;6. doi:&#xa0;10.1016/j.biocel.2010.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2010.06.021</ArticleId><ArticleId IdType="pubmed">20599520</ArticleId></ArticleIdList></Reference><Reference><Citation>Loane DJ, Kumar A. Microglia in the TBI brain: The good, the bad, and the dysregulated. Exp Neurol (2016) 275 Pt 3(0 3):316&#x2013;27. doi:&#xa0;10.1016/j.expneurol.2015.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.08.018</ArticleId><ArticleId IdType="pmc">PMC4689601</ArticleId><ArticleId IdType="pubmed">26342753</ArticleId></ArticleIdList></Reference><Reference><Citation>Otxoa-de-Amezaga A, Mir&#xf3;-Mur F, Pedragosa J, Gallizioli M, Justicia C, Gaja-Capdevila N, et al. . Microglial cell loss after ischemic stroke favors brain neutrophil accumulation. Acta Neuropathol (2019) 137(2):321&#x2013;41. doi:&#xa0;10.1007/s00401-018-1954-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1954-4</ArticleId><ArticleId IdType="pmc">PMC6513908</ArticleId><ArticleId IdType="pubmed">30580383</ArticleId></ArticleIdList></Reference><Reference><Citation>Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S, et al. . Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci (2009) 29(37):11511&#x2013;22. doi:&#xa0;10.1523/JNEUROSCI.1514-09.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1514-09.2009</ArticleId><ArticleId IdType="pmc">PMC2768309</ArticleId><ArticleId IdType="pubmed">19759299</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L, Poteet EC, Li W, Scott AE, Liu R, Wen Y, et al. . Modulation of polymorphonuclear neutrophil functions by astrocytes. J Neuroinflamm (2010) 7:53. doi:&#xa0;10.1186/1742-2094-7-53</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-53</ArticleId><ArticleId IdType="pmc">PMC2942816</ArticleId><ArticleId IdType="pubmed">20828397</ArticleId></ArticleIdList></Reference><Reference><Citation>Stirling DP, Liu S, Kubes P, Yong VW. Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome. J Neurosci (2009) 29(3):753&#x2013;64. doi:&#xa0;10.1523/JNEUROSCI.4918-08.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4918-08.2009</ArticleId><ArticleId IdType="pmc">PMC6665178</ArticleId><ArticleId IdType="pubmed">19158301</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooshmand MJ, Nguyen HX, Piltti KM, Benavente F, Hong S, Flanagan L, et al. . Neutrophils induce astroglial differentiation and migration of human neural stem cells via C1q and C3a synthesis. J Immunol (2017) 199(3):1069&#x2013;85. doi:&#xa0;10.4049/jimmunol.1600064</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600064</ArticleId><ArticleId IdType="pmc">PMC5523578</ArticleId><ArticleId IdType="pubmed">28687659</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipollina G, Davari Serej A, Di Nolfi G, Gazzano A, Marsala A, Spatafora MG, et al. . Heterogeneity of neuroinflammatory responses in amyotrophic lateral sclerosis: A challenge or an opportunity. Int J Mol Sci (2020) 21(21). doi:&#xa0;10.3390/ijms21217923</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21217923</ArticleId><ArticleId IdType="pmc">PMC7662281</ArticleId><ArticleId IdType="pubmed">33113845</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz M, Priller J. The role of peripheral immune cells in the CNS in steady state and disease. Nat Neurosci (2017) 20(2):136&#x2013;44. doi:&#xa0;10.1038/nn.4475</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4475</ArticleId><ArticleId IdType="pubmed">28092660</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Wang Y, Huang J, Hu B, Huang W. Identification of immune-related hub genes in parkinson's disease. Front Genet (2022) 13:914645. doi:&#xa0;10.3389/fgene.2022.914645</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.914645</ArticleId><ArticleId IdType="pmc">PMC9353688</ArticleId><ArticleId IdType="pubmed">35938039</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Camarillo C, Alem&#xe1;n OR, Rosales C. Low-density neutrophils in healthy individuals display a mature primed phenotype. Front Immunol (2021) 12:672520. doi:&#xa0;10.3389/fimmu.2021.672520</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.672520</ArticleId><ArticleId IdType="pmc">PMC8285102</ArticleId><ArticleId IdType="pubmed">34276661</ArticleId></ArticleIdList></Reference><Reference><Citation>Obama T, Itabe H. Neutrophils as a novel target of modified low-density lipoproteins and an accelerator of cardiovascular diseases. Int J Mol Sci (2020) 21(21). doi:&#xa0;10.3390/ijms21218312</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218312</ArticleId><ArticleId IdType="pmc">PMC7664187</ArticleId><ArticleId IdType="pubmed">33167592</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho Y, Bukong TN, Tornai D, Babuta M, Vlachos IS, Kanata E, et al. . Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis. J Hepatol (2023) 78(1):28&#x2013;44. doi:&#xa0;10.1016/j.jhep.2022.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2022.08.029</ArticleId><ArticleId IdType="pubmed">36063965</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>